BLT 0.00% 2.6¢ benitec biopharma limited

If we are good enough at selling ourselves we could be part of a...

  1. 4,015 Posts.
    lightbulb Created with Sketch. 127
    If we are good enough at selling ourselves we could be part of a cash rich pharma industry M&A upswing in 2013.

    According to Bloomberg big pharma has over $70B in cash reserves that it is looking invest.

    "Get ready for the return of the $10 billion-plus drug deal.

    Pharmaceutical companies including Pfizer Inc. (PFE) and Bristol- Myers Squibb Co. (BMY) have spent the last several years digesting earlier acquisitions, refocusing their product development and setting aside cash in anticipation of expiring patents. Now, the expectation is they’re ready to start buying again. Led by Pfizer, in New York, and Whitehouse Station, New Jersey-based Merck & Co. (MRK), five of the largest U.S. drugmakers had more than $70 billion in cash, near cash and short-term investments at the end of the third quarter."

    This is all on the table at the JPMorgan’s annual health-care conference so, if the cash is there and we have the technology, what is standing in the way of us getting some of this dough?

    http://www.bloomberg.com/news/2013-01-07/pharma-deals-north-of-10-billion-seen-returning-in-2013.html
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.